{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T18:48:30Z","timestamp":1790707710045,"version":"4.1.0"},"reference-count":43,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2019,11,29]],"date-time":"2019-11-29T00:00:00Z","timestamp":1574985600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"funder":[{"DOI":"10.13039\/100002491","name":"Bristol-Myers Squibb","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002491","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["T32\u2010AR\u20107530\u201033"],"award-info":[{"award-number":["T32\u2010AR\u20107530\u201033"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["acrjournals.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Arthritis Care &amp;amp; Research"],"published-print":{"date-parts":[[2020,1]]},"abstract":"<jats:sec><jats:title>Objective<\/jats:title><jats:p>We aimed to evaluate the comparative risk of hospitalized infection among patients with rheumatoid arthritis (<jats:styled-content style=\"fixed-case\">RA<\/jats:styled-content>) who initiated abatacept versus a tumor necrosis factor inhibitor (<jats:styled-content style=\"fixed-case\">TNF<\/jats:styled-content>i).<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Using claims data from Truven MarketScan database (2006\u20132015), we identified patients with <jats:styled-content style=\"fixed-case\">RA<\/jats:styled-content> ages \u226518 years with \u22652 <jats:styled-content style=\"fixed-case\">RA<\/jats:styled-content> diagnoses who initiated treatment with abatacept or a <jats:styled-content style=\"fixed-case\">TNF<\/jats:styled-content>i. The primary outcome was a composite end point of any hospitalized infection. Secondary outcomes included bacterial infection, herpes zoster, and infections affecting different organ systems. We performed 1:1 propensity score (<jats:styled-content style=\"fixed-case\">PS<\/jats:styled-content>) matching between the groups in order to control for baseline confounders. We estimated incidence rates (<jats:styled-content style=\"fixed-case\">IRs<\/jats:styled-content>) and hazard ratios (<jats:styled-content style=\"fixed-case\">HR<\/jats:styled-content>s) with 95% confidence intervals (95% <jats:styled-content style=\"fixed-case\">CI<\/jats:styled-content>s) for hospitalized infection.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>We identified 11,248 <jats:styled-content style=\"fixed-case\">PS<\/jats:styled-content>\u2010matched pairs of patients who initiated treatment with abatacept and <jats:styled-content style=\"fixed-case\">TNF<\/jats:styled-content>i with a median age of 56 years (83% were women). The <jats:styled-content style=\"fixed-case\">IR<\/jats:styled-content> per 1,000 person\u2010years for any hospitalized infection was 37 among patients who initiated treatment with abatacept and 47 in those who initiated treatment with <jats:styled-content style=\"fixed-case\">TNF<\/jats:styled-content>i. The <jats:styled-content style=\"fixed-case\">HR<\/jats:styled-content> for the risk of any hospitalized infection associated with abatacept versus <jats:styled-content style=\"fixed-case\">TNF<\/jats:styled-content>i was 0.78 (95% <jats:styled-content style=\"fixed-case\">CI<\/jats:styled-content> 0.64\u20130.95) and remained lower when compared to infliximab (<jats:styled-content style=\"fixed-case\">HR<\/jats:styled-content> 0.63 [95% <jats:styled-content style=\"fixed-case\">CI<\/jats:styled-content> 0.47\u20130.85]), while no significant difference was seen when compared to adalimumab and etanercept. The risk of secondary outcomes was lower for abatacept for pulmonary infections, and similar to <jats:styled-content style=\"fixed-case\">TNF<\/jats:styled-content>i for the remaining outcomes.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>In this large cohort of patients with <jats:styled-content style=\"fixed-case\">RA<\/jats:styled-content> who initiated treatment with abatacept or <jats:styled-content style=\"fixed-case\">TNF<\/jats:styled-content>i as a first\u2010 or second\u2010line biologic agent, we found a lower risk of hospitalized infection after initiating abatacept versus <jats:styled-content style=\"fixed-case\">TNF<\/jats:styled-content>i, which was driven mostly by infliximab.<\/jats:p><\/jats:sec>","DOI":"10.1002\/acr.23824","type":"journal-article","created":{"date-parts":[[2018,12,20]],"date-time":"2018-12-20T11:09:57Z","timestamp":1545304197000},"page":"9-17","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":47,"title":["Risk of Hospitalized Infection and Initiation of Abatacept Versus Tumor Necrosis Factor Inhibitors Among Patients With Rheumatoid Arthritis: A Propensity Score\u2013Matched Cohort Study"],"prefix":"10.1002","volume":"72","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8206-597X","authenticated-orcid":false,"given":"Sarah K.","family":"Chen","sequence":"first","affiliation":[{"name":"Brigham and Women\u2019s Hospital Harvard Medical School  Boston Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4797-3200","authenticated-orcid":false,"given":"Katherine P.","family":"Liao","sequence":"additional","affiliation":[{"name":"Brigham and Women\u2019s Hospital Harvard Medical School  Boston Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Liu","sequence":"additional","affiliation":[{"name":"Brigham and Women\u2019s Hospital Harvard Medical School  Boston Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2517-3579","authenticated-orcid":false,"given":"Seoyoung C.","family":"Kim","sequence":"additional","affiliation":[{"name":"Brigham and Women\u2019s Hospital Harvard Medical School  Boston Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2019,11,29]]},"reference":[{"key":"e_1_2_6_2_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.10524"},{"key":"e_1_2_6_3_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780290602"},{"key":"e_1_2_6_4_1","first-page":"387","article-title":"The risk of hospitalized infection in patients with rheumatoid arthritis","volume":"35","author":"Smitten AL","year":"2008","journal-title":"J Rheumatol"},{"key":"e_1_2_6_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1521-6942(03)00041-X"},{"key":"e_1_2_6_6_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.95.24.14447"},{"key":"e_1_2_6_7_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.21386"},{"key":"e_1_2_6_8_1","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kes283"},{"key":"e_1_2_6_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinthera.2011.05.044"},{"key":"e_1_2_6_10_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2009.146"},{"key":"e_1_2_6_11_1","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keg263"},{"key":"e_1_2_6_12_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa050524"},{"key":"e_1_2_6_13_1","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2007.083188"},{"key":"e_1_2_6_14_1","doi-asserted-by":"publisher","DOI":"10.1186\/ar2984"},{"key":"e_1_2_6_15_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.22070"},{"key":"e_1_2_6_16_1","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-144-12-200606200-00003"},{"key":"e_1_2_6_17_1","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2010.146365"},{"key":"e_1_2_6_18_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.39399"},{"key":"e_1_2_6_19_1","doi-asserted-by":"publisher","DOI":"10.1002\/acr.22281"},{"key":"e_1_2_6_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2012.12.024"},{"key":"e_1_2_6_21_1","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.131464"},{"key":"e_1_2_6_22_1","doi-asserted-by":"publisher","DOI":"10.1186\/ar3260"},{"key":"e_1_2_6_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2010.10.004"},{"key":"e_1_2_6_24_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.39075"},{"key":"e_1_2_6_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2006.07.011"},{"key":"e_1_2_6_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2008.06.006"},{"key":"e_1_2_6_27_1","doi-asserted-by":"publisher","DOI":"10.1093\/aje\/kwy078"},{"key":"e_1_2_6_28_1","doi-asserted-by":"publisher","DOI":"10.1080\/03610910902859574"},{"key":"e_1_2_6_29_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2016-209131"},{"key":"e_1_2_6_30_1","doi-asserted-by":"publisher","DOI":"10.1002\/acr.22470"},{"key":"e_1_2_6_31_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2012-201338"},{"key":"e_1_2_6_32_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2006.02.001"},{"key":"e_1_2_6_33_1","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.301.2.418"},{"key":"e_1_2_6_34_1","doi-asserted-by":"publisher","DOI":"10.1006\/cyto.1995.0029"},{"key":"e_1_2_6_35_1","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2010.128637"},{"key":"e_1_2_6_36_1","first-page":"1952","article-title":"Can severity be predicted by treatment variables in rheumatoid arthritis administrative data bases?","volume":"33","author":"Wolfe F","year":"2006","journal-title":"J Rheumatol"},{"key":"e_1_2_6_37_1","doi-asserted-by":"publisher","DOI":"10.1186\/ar2482"},{"key":"e_1_2_6_38_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13075-015-0599-0"},{"key":"e_1_2_6_39_1","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.110587"},{"key":"e_1_2_6_40_1","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(94)90131-7"},{"key":"e_1_2_6_41_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.10529"},{"key":"e_1_2_6_42_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.22600"},{"key":"e_1_2_6_43_1","doi-asserted-by":"publisher","DOI":"10.1377\/hlthaff.24.2.343"},{"key":"e_1_2_6_44_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0033-3549(04)50253-4"}],"container-title":["Arthritis Care &amp; Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Facr.23824","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/acr.23824","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/acr.23824","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/acrjournals.onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/acr.23824","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T15:04:56Z","timestamp":1759417496000},"score":1,"resource":{"primary":{"URL":"https:\/\/acrjournals.onlinelibrary.wiley.com\/doi\/10.1002\/acr.23824"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11,29]]},"references-count":43,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,1]]}},"alternative-id":["10.1002\/acr.23824"],"URL":"https:\/\/doi.org\/10.1002\/acr.23824","archive":["Portico"],"relation":{},"ISSN":["2151-464X","2151-4658"],"issn-type":[{"value":"2151-464X","type":"print"},{"value":"2151-4658","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,11,29]]},"assertion":[{"value":"2018-08-01","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-12-04","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-11-29","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}